Kogelox

Levofloxacin has:

• Gram-Positive Activity: This agent demonstrates enhanced activity against both penicillin-sensitive and penicillin-resistant gram-positive organisms, most notably Streptococcus pneumoniae.

• Respiratory Pathogen Coverage: It is highly effective against common respiratory organisms, including Haemophilus influenzae, Moraxella catarrhalis, Legionella spp, Mycoplasma spp, and Chlamydia pneumoniae.

• Antitubercular Properties: The medication exhibits superior in-vitro activity against Mycobacterium tuberculosis and is recognized as the preferred second-line antitubercular therapy over other fluoroquinolones.